GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Shiller PE Ratio

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Shiller PE Ratio : 19.89 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Starry Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-27), Zhejiang Starry Pharmaceutical Co's current share price is ¥11.14. Zhejiang Starry Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.56. Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio for today is 19.89.

The historical rank and industry rank for Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SHSE:603520' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.9   Med: 19.94   Max: 23.38
Current: 19.89

During the past years, Zhejiang Starry Pharmaceutical Co's highest Shiller PE Ratio was 23.38. The lowest was 14.90. And the median was 19.94.

SHSE:603520's Shiller PE Ratio is ranked better than
62.06% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.51 vs SHSE:603520: 19.89

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Starry Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.040. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.56 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Starry Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Starry Pharmaceutical Co Shiller PE Ratio Chart

Zhejiang Starry Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 22.60

Zhejiang Starry Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 22.60 21.46

Competitive Comparison of Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio falls into.



Zhejiang Starry Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=11.14/0.56
=19.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Starry Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Zhejiang Starry Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.04/115.2271*115.2271
=0.040

Current CPI (Mar. 2024) = 115.2271.

Zhejiang Starry Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.400 95.237 0.484
201312 0.710 97.624 0.838
201412 0.750 99.000 0.873
201503 0.139 99.900 0.160
201506 0.031 99.500 0.036
201509 0.029 100.500 0.033
201512 0.080 100.600 0.092
201603 0.102 102.200 0.115
201606 0.062 101.400 0.070
201609 0.047 102.400 0.053
201612 0.040 102.600 0.045
201703 0.084 103.200 0.094
201706 0.080 103.100 0.089
201709 0.047 104.100 0.052
201712 0.040 104.500 0.044
201803 0.066 105.300 0.072
201806 0.130 104.900 0.143
201809 0.082 106.600 0.089
201812 0.027 106.500 0.029
201903 0.122 107.700 0.131
201906 0.163 107.700 0.174
201909 0.129 109.800 0.135
201912 0.100 111.200 0.104
202003 0.136 112.300 0.140
202006 0.286 110.400 0.299
202009 0.179 111.700 0.185
202012 0.114 111.500 0.118
202103 0.186 112.662 0.190
202106 0.274 111.769 0.282
202109 0.180 112.215 0.185
202112 0.300 113.108 0.306
202203 0.240 114.335 0.242
202206 -0.050 114.558 -0.050
202209 -0.130 115.339 -0.130
202212 -0.280 115.116 -0.280
202303 0.030 115.116 0.030
202306 0.070 114.558 0.070
202309 0.010 115.339 0.010
202312 0.020 114.781 0.020
202403 0.040 115.227 0.040

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Starry Pharmaceutical Co  (SHSE:603520) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zhejiang Starry Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Starry Pharmaceutical Co (SHSE:603520) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Executives
Hu Jin Sheng Director

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Headlines

No Headlines